AlphaStocks
7.2
Consider Buy

GLOBUS MEDICAL INC (GMED)

Health Care / Health Care Equipment

S&P MidCap 400

$87.75

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 5 of 5 models — high confidence

#73out of 1127 in Health Care

Is GLOBUS MEDICAL INC a Good Investment in 2026?

GLOBUS MEDICAL INC (GMED) scores 7.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates GLOBUS MEDICAL INC as Strong (9/9). The Greenblatt Magic Formula model is the least favorable, rating it Neutral. GLOBUS MEDICAL INC currently trades below its estimated fair value of $105, suggesting potential upside. GLOBUS MEDICAL INC ranks #73 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.4ROE12.0

Estimated Fair Value

$104.6016% below

Fair value above market price. EPS grew 425% year-over-year. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

9/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

54% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Neutral

Top half (rank 47%)

Frequently Asked Questions

Is GLOBUS MEDICAL INC (GMED) a good investment?
Based on AlphaStocks' composite analysis, GLOBUS MEDICAL INC (GMED) scores 7.2 out of 10, earning a Consider Buy rating. This places it above average across most investment dimensions. Fair value above market price. EPS grew 425% year-over-year. P/E of 22x is moderate for this quality level.
What is GLOBUS MEDICAL INC's Piotroski F-Score?
GLOBUS MEDICAL INC's Piotroski F-Score status is Strong. The raw score is 9/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is GMED overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $105, GMED appears undervalued. The stock currently trades 16% below its estimated fair value. Fair value above market price. EPS grew 425% year-over-year. P/E of 22x is moderate for this quality level.
How does GMED compare to other Health Care stocks?
GLOBUS MEDICAL INC ranks #73 out of 1127 stocks in the Health Care sector, placing it in the top 6% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about GMED?
AlphaStocks evaluates GMED using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 7.2/10.

Similar Stocks

PARRFTIAZN

Compare GMED with

GMED vs PARRGMED vs FTIGMED vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer